A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Pediatrics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/PEDS.107.1.30PMID 11134430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor.

  2000cited by this paper
• Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis.

  1999cited by this paper
• A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates.

  1999cited by this paper
• A Randomized, Controlled Trial of Prophylactic Granulocyte-Macrophage Colony-Stimulating Factor in Human Newborns Less Than 32 Weeks Gestation

  1999cited by this paper
• A Randomized, Placebo-Controlled Trial of Granulocyte Colony-stimulating Factor Administration to Newborn Infants With Neutropenia and Clinical Signs of Early-onset Sepsis

  1998cited by this paper
• Interleukin 6 in neonates with early and late onset infection.

  1997cited by this paper
• The in vivo effect of recombinant human granulocyte-colony stimulating factor in neutropenic neonates with sepsis

  1997cited by this paper
• Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network.

  1996cited by this paper
• Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats.

  1996cited by this paper
• Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network.

  1996cited by this paper
• Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates.

  1996cited by this paper
• Granulocyte colony stimulating factor treatment for neonatal neutropenia.

  1995cited by this paper
• Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases.

  1995cited by this paper
• Diagnostic value of plasma levels of tumor necrosis factor α (TNFα) and interleukin‐6 (IL‐6) in newborns with sepsis

  1994cited by this paper
• The failure of newborn mice infected with Escherichia coli to accelerate neutrophil production correlates with their failure to increase transcripts for granulocyte colony-stimulating factor and interleukin-6.

  1993cited by this paper
• Therapeutic implications of dysregulated colony-stimulating factor expression in neonates.

  1993cited by this paper
• Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections.

  1993cited by this paper
• Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates.

  1993cited by this paper
• Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care.

  1993cited by this paper
• Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis.

  1992cited by this paper
• Decreased G-CSF and IL-3 Production and Gene Expression from Mononuclear Cells of Newborn Infants

  1992cited by this paper
• Neonatal sepsis.

  1992cited by this paper
• Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.

  1992cited by this paper
• Granulocyte colony-stimulating factor and its receptor.

  1991cited by this paper
• Prophylactic or Simultaneous Administration of Recombinant Human Granulocyte Colony Stimulating Factor in the Treatment of Group B Streptococcal Sepsis in Neonatal Rats

  1990cited by this paper
• Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.

  1990cited by this paper
• Biochemical, Structural, and Functional Abnormalities of Polymorphonuclear Leukocytes in the Neonate

  1987cited by this paper
• The neonatal blood count in health and disease. I. Reference values for neutrophilic cells.

  1979cited by this paper

• Sepsis: the evolution of molecular pathogenesis concepts and clinical management

  2025cites this paper
• Nootropic foods in neurodegenerative diseases: mechanisms, challenges, and future

  2025cites this paper
• Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in modulating inflammation and its resolution

  2023cites this paper
• Adjuvant therapy in neonatal sepsis to prevent mortality - A systematic review and network meta-analysis

  2022cites this paper
• A Role for Data Science in Precision Nutrition and Early Brain Development

  2022cites this paper
• Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials

  2022cites this paper
• Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies?

  2022cites this paper
• Salivary proteome of aphthous stomatitis reveals the participation of vitamin metabolism, nutrients, and bacteria

  2021cites this paper
• Sepsis, Cytokine Storms, and Immunopathology: The Divide between Neonates and Adults

  2021cites this paper
• Neonatal sepsis definitions from randomised clinical trials

  2021cites this paper
• Sepsis, Cytokine Storms, and Immunopathology: The Divide

  2021cites this paper
• Dysregulated Mucosal Immunity and Associated Pathogeneses in Preterm Neonates

  2020cites this paper
• Medicinal Uses of Hematopoietic Growth Factors in Neonatal Medicine.

  2019cites this paper
• Thrombocytopenia in the Newborn

  2019cites this paper
• Clinical and Biochemical Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on the Prognosis of Preterm Infants with Early Onset Neonatal Sepsis

  2019cites this paper
• Granulocyte Colony Stimulating Factor in Improving Outcomes of Neonatal Sepsis: A Meta-Analysis

  2018cites this paper
• Can Recombinant Granulocyte Colony Stimulating Factor Modulate Inflammatory Response in Extreme Low Gestational Age Newborns?: Effect of rhG-CSF on Cytokines in ELGAN

  2017cites this paper
• 115 – Developmental Granulocytopoiesis

  2017cites this paper
• Recombinant G-CSF Treatment of Severe Chronic Neutropenia in Neonates and Infants

  2016cites this paper
• Effectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia

  2016cites this paper
• Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.

  2014cites this paper
• Enhanced Survival During Experimental Listeria monocytogenes Sepsis in Neonatal Mice Prophylactically Treated With Th1 and Macrophage Immunoregulatory Cytokines and Mediators

  2014cites this paper
• The Effect of Granulocyte Colony Stimulating Factor Administration on Preterm Infant with Neutropenia and Clinical Sepsis: A Randomized Clinical Trial

  2013cites this paper
• Neutropenia in the newborn

  2013cites this paper
• Chapter 45 – Thrombocytopenia in the Newborn

  2013cites this paper
• Temporal alteration of serum G-CSF and VEGF levels in perinatal asphyxia treated with head cooling.

  2012cites this paper
• In Vivo Effect of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutrophilic Expression of CD11b in Septic Neonates: A Randomized Controlled Trial

  2012influential citation
• Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.

  2012cites this paper
• Therapy with Recombinant Leukocyte Growth Factors

  2012cites this paper
• Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?

  2012cites this paper
• Care of the Extremely Low-Birthweight Infant

  2012cites this paper
• A Practical Approach to the Neutropenic Neonate

  2012cites this paper
• The role of haemopoietic colony- stimulating factors in the management of newborn infection

  2012cites this paper
• Ethnic differences in body fat distribution among Asian pre-pubertal children: A cross-sectional multicenter study

  2011cites this paper
• Infection Control for Healthcare-Associated Infections in Pediatric Patients

  2011cites this paper
• GENERAL ARTICLE Neonatal Sepsis and Neutrophil Insufficiencies

  2010cites this paper
• Neonatal Sepsis and Neutrophil Insufficiencies

  2010cites this paper
• Published Pediatric Randomized Drug Trials in Developing Countries, 1996–2002

  2010cites this paper
• Thrombocytopenia and neutropenia among extremely low birth weight neonates

  2009cites this paper
• A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia.

  2009cites this paper
• Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis

  2009cites this paper
• Pitfalls in the design and analysis of paediatric clinical trials: a case of a ‘failed’ multi-centre study, and potential solutions

  2008cites this paper
• Temporal alterations in concentrations of sera cytokines/chemokines in sepsis due to group B streptococcus infection in a neonate.

  2008cites this paper
• GRANULOCYTE-MACROPHAGE-COLONY-STIMULATING FACTOR-DEPENDENT PERITONEAL MACROPHAGE RESPONSES DETERMINE SURVIVAL IN EXPERIMENTALLY INDUCED PERITONITIS AND SEPSIS IN MICE

  2008cites this paper
• Inhibition of Poly(Adenosine Diphosphate–Ribose) Polymerase Attenuates Ventilator-induced Lung Injury

  2008cites this paper
• Chapter 3 – The Role of Recombinant Leukocyte Colony-Stimulating Factors in the Neonatal Intensive Care Unit

  2008cites this paper
• Altersabhängige Modulation der Endotoxin-induzierten Schädigung der Rattenleber durch Granulozyten-Kolonie-stimulierenden Faktor (G-CSF)

  2007cites this paper
• Intravenous immunoglobulins and haematopoietic growth factors in the prevention and treatment of neonatal sepsis: ground reality or glorified myths?

  2007cites this paper
• Epo and other hematopoietic factors.

  2007cites this paper
• CHAPTER 52 – Thrombocytopenia in the Newborn

  2007cites this paper
• Immunomodulation, Part II: Granulocyte Colony-Stimulating Factors

  2006cites this paper
• Colony stimulating factors as adjunctive therapy in neonatal sepsis

  2006cites this paper
• Controversies in neonatal sepsis: immunomodulation in the treatment and prevention of neonatal sepsis.

  2006cites this paper
• Shock séptico por Pseudomonas aeruginosa adquirido en la comunidad asociado a neutropenia, en un paciente previamente sano

  2006cites this paper
• Serine proteinases of the human body louse (Pediculus humanus): sequence characterization and expression patterns

  2005cites this paper
• Dysregulation of Expression of Immunoregulatory and Cytokine Genes and Its Association with the Immaturity in Neonatal Phagocytic and Cellular Immunity

  2005cites this paper
• Chapter 39 – Bacterial Sepsis and Meningitis

  2005cites this paper
• Chapter 145 – Developmental Granulocytopoiesis

  2004cites this paper
• Neutropenia in the Neonatal Intensive Care Unit

  2004cites this paper
• Adjunct therapies to bacterial sepsis in the neonate

  2004cites this paper
• Is there a place for granulocyte colony-stimulating factor in non-neutropenic critically ill patients?

  2004cites this paper
• Adjunct to Bacterial Sepsis in the Neonate

  2004cites this paper
• Recombinant cytokines in augmentation and immunomodulation of host defenses against Candida spp.

  2004cites this paper
• Haemopoietic growth factors for neonates: assessing risks and benefits

  2004cites this paper
• Neonatal transfusion practice

  2004cites this paper
• HLA-DR regulation and the influence of GM-CSF on transcription, surface expression and shedding

  2004cites this paper
• G-CSF immunotherapy for treatment of acute disseminated murine melioidosis.

  2003cites this paper
• How to leverage an endogenous immune defense mechanism: the example of granulocyte colony-stimulating factor.

  2003cites this paper
• Review of common therapeutic options in the United States for the treatment of pediculosis capitis.

  2003cites this paper
• [Neonatal neutropenia, nosocomial infection and granulocyte-colony stimulating factor].

  2003cites this paper
• Neonatal Sepsis

  2003cites this paper
• Thrombocytopenia in the newborn

  2003cites this paper
• Passive immunization as prophylaxis: when and where will this work?

  2003cites this paper
• Neutropénie néonatale, infection nosocomiale précoce et granulocyte-colony stimulating factor

  2003cites this paper
• G-CSF and GM-CSF for treating or preventing neonatal infections.

  2003cites this paper
• Messenger RNA Expression of Granulocyte Colony-Stimulating Factor Receptor Isoforms in the Fetus

  2003cites this paper
• Combinatorial immunotherapies for infectious diseases.

  2003cites this paper
• Name of Herb Ginger Scientific and Common Names Zingiber officinale

  2003cites this paper
• Immunotherapy in the prophylaxis and treatment of neonatal sepsis

  2003cites this paper
• What is the rationale for the use of granulocyte and granulocyte‐macrophage colony‐stimulating factors in the neonatal intensive care unit

  2002cites this paper
• HAEMATOPOIETIC GROWTH FACTORS IN CHILDREN WITH NEUTROPENIA

  2002influential citation
• In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates.

  2002cites this paper
• A practical approach to neutrophil disorders.

  2002cites this paper
• Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis.

  2002cites this paper
• Use of myeloid colony-stimulating factors in neonates with septicemia

  2002cites this paper
• [New treatment approaches in sepsis].

  2002cites this paper
• Perinatal immunomodulation

  2002cites this paper
• Perinatal immunomodulation.

  2002cites this paper
• The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis.

  2002cites this paper
• What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit?

  2002cites this paper
• Randomized, Double-blinded, Placebo-controlled Trial of Early Administration of Recombinant Human Granulocyte Colony-stimulating Factor to Non-neutropenic Preterm Newborns Between 33 and 36 Weeks with Presumed Sepsis

  2002influential citation
• Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants

  2002cites this paper
• A woman with an extremely premature newborn.

  2001cites this paper
• Immunotherapy of sepsis

  2001cites this paper
• [Use of blood and blood components and derivatives in newborn infants]

  2001cites this paper
• Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: A meta-analysis.

  2001cites this paper
• Hämatopoetische Wachstumsfaktoren in Prophylaxe und Therapie infektiöser Komplikationen bei Früh- und Neugeborenen1

  2001cites this paper
• Immunotherapy of sepsis.

  2001cites this paper
• Neonatal sepsis: a systematic review of core outcomes from Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials randomised clinical trials

  year unknowncites this paper